Instead, we took an unbiased screening approach to identify drugs with single agent efficacy against platinum resistant, MYC expressing SCLC cell lines and identified the dual PI3K-HDAC inhibitor fimepinostat. The gene discussed is HDAC9; the disease is small cell lung carcinoma.